Sanofi India Board Approves Q1 FY26 Results, Appoints New Chairman

Sanofi India's Board of Directors, at its meeting on April 28, 2026, considered and approved the unaudited financial results for the quarter ended March 31, 2026. The board also announced the completion of tenure for Independent Directors Mr. Aditya Narayan and Mrs. Usha Thorat, effective April 29, 2026. Mr. Rahul Bhatnagar was appointed as the new Chairman of the Board, effective April 30, 2026. Furthermore, the company re-constituted its Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and Corporate Social Responsibility Committee, also effective April 30, 2026.